Clinical trial news.
Rusfertide, a Hepcidin Mimetic, for Control of E... - MPN Voice
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera
Written by
Lena70
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Thanks for posting
Not what you're looking for?
You may also like...
Rusfertide (for HCT Control)- FDA status
I came across this info today.
Mar 28 2024: "Protagonist Therapeutics said it plans to seek FDA...
Recombinant Interferon-β in the Treatment of Polycythemia Vera
Simple Summary:
« The myeloproliferative neoplasms (MPNs) are chronic blood cancers...
How high is your WBC in polycythemia vera?
Hey all how often does your WBC fluctuate. Mine hover around 8 to 14 They say some variations is...
FDA Rejects Ropeginterferon alfa-2b for Polycythemia Vera
« The drug development process is not always easy or quick. It consists of drug discovery,...
Phyllis George dies of polycythemia Vera at age 70
https://www.nkytribune.com/2020/05/phyllis-george-former-miss-america-and-first-lady-of-kentucky-die
Related Posts
Correction of polycythemia vera via CRISPR/AAV6 genome editing
FDA Approves Ropeginterferon Alfa-2b-njft for Polycythemia Vera
Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera- Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
Observational REVEAL Study Highlights Potential Risk Factors for Disease Transformation in Polycythemia Vera
